Package 59651-453-60

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 59651-453-60
Digits Only 5965145360
Product NDC 59651-453
Product ID 59651-453_a0368fb7-1837-44ab-b9f2-c1267068cc89
Description

60 CAPSULE in 1 BOTTLE (59651-453-60)

Marketing

Marketing Status
Marketed Since 2023-09-27
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

TOPIRAMATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a0368fb7-1837-44ab-b9f2-c1267068cc89", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["205315", "205316"], "spl_set_id": ["d1588c37-9da9-4ccb-b78a-64234938a115"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (59651-453-60)", "package_ndc": "59651-453-60", "marketing_start_date": "20230927"}], "brand_name": "TOPIRAMATE", "product_id": "59651-453_a0368fb7-1837-44ab-b9f2-c1267068cc89", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "59651-453", "generic_name": "TOPIRAMATE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA215449", "marketing_category": "ANDA", "marketing_start_date": "20230927", "listing_expiration_date": "20261231"}